Skip to main content

Table 1 The physical health of adults with intellectual disability

From: The physical health of British adults with intellectual disability: cross sectional study

 

Prevalence (ID)

Prevalence (no ID)

Unadjusted Odds

Model 1: Odds adjusted for age and gender

Model 2: Odds adjusted for age, gender, socio-economic disadvantage and neighborhood social capital

General Physical Health (W3)

‘Poor’ self-rated health

13 %

3 %

4.40*** (3.12-6.21)

3.89*** (2.74-5.53)

1.92*** (1.32-2.79)

SF-12 Physical Component (bottom 10 % of weighted sample)

28 %

10 %

3.66*** (2.61-5.12)

3.49*** (2.48-4.91)

2.20*** (1.54-3.14)

Self-Reported Health Conditions (W1-4)

Asthma

9 %

12 %

0.80 (0.53-1.21)

0.85 (0.56-1.29)

0.75 (0.49-1.14)

Arthritis

7 %

3 %

2.86*** (1.77-4.61)

2.31** (1.42-3.76)

1.52 (0.92-2.51)

Cancer or malignancy

2 %

1 %

2.64* (1.07-6.49)

2.14 (0.87-5.29)

1.65 (0.66-4.17)

Diabetes

6 %

2 %

4.53*** (2.77-7.40)

3.90*** (2.37-6.40)

2.44** (1.47-4.07)

Epilepsy

2 %

1 %

2.52* (1.11-5.74)

2.53* (1.11-5.76)

1.67 (0.72-3.84)

Thyroid disorder

2 %

2 %

1.20 (0.49-2.93)

0.95 (0.39-2.33)

0.78 (0.31-1.93)

Respiratory disordera

1 %

1 %

1.74 (0.55-5.51)

1.44 (0.45-4.57)

0.78 (0.24-2.52)

High blood pressure

5 %

5 %

1.04 (0.60-1.79)

0.87 (0.50-1.51)

0.69 (0.40-1.20)

Other CVDb

3 %

1 %

3.91*** (1.90-8.02)

3.34** (1.62-6.89)

2.02 (0.97-4.23)

Any morbidity

24 %

22 %

1.18 (0.90-1.55)

1.27 (0.96-1.67)

1.09 (0.82-1.44)

Multiple morbidity

2+

8 %

4 %

2.63*** (1.72-4.00)

2.25*** (1.47-3.42)

1.39 (0.90-2.16)

3+

2 %

1 %

2.45* (1.08-5.57)

2.00 (0.88-4.57)

1.02 (0.44-2.39)

Hospital admission for newly diagnosed condition (W2-4)

7 %

2 %

2.64*** (1.51-4.59)

2.53** (1.45-4.41)

1.98* (1.13-3.49)

Nurse measures (W2 or 3)

Obese

42 %

26 %

2.12** (1.25-3.60)

2.12** (1.24-3.62)

1.67 (0.97-2.87)

Stage 2 hypertension or on medication

2 %

4 %

0.56 (0.08-4.10)

0.51 (0.07-3.75)

0.32 (0.04-2.40)

Grip strength for dominant hand (bottom 10 % of weighted sample)

32 %

9 %

4.46*** (2.50-7.95)

7.10*** (3.64-13.98)

5.94*** (2.98-11.84)

Lung function

Fev1 (bottom 10 % of weighted sample)

30 %

9 %

4.53*** (2.40-8.52)

5.67*** (2.78-11.56)

4.34*** (2.10-8.96)

Fvc (bottom 10 % of weighted sample)

28 %

8 %

4.56*** (2.38-8.68)

6.79*** (3.12-14.77)

5.13*** (2.33-11.29)

Fev1/fvc ratio (bottom 10 % of weighted sample)

17 %

10 %

1.90 (0.88-4.08)

1.77 (0.81-3.84)

1.57 (0.72-3.45)

Peak expiratory flow (bottom 10 % of weighted sample)

37 %

8 %

6.76*** (3.69-12.36)

9.50*** (4.89-18.48)

7.14*** (3.63-14.04)

Polypharmacy (taking 5+ meds)

8 %

4 %

2.56* (1.02-6.44)

2.40 (0.94-6.13)

1.15 (0.44-3.05)

Polypharmacy (taking 5+ meds)c

   

2.07 (0.74-5.74)

1.19 (0.42-3.40)

  1. Odds: Odds ratio with 95 % confidence intervals. Odds ratios in bold equivalent to moderate or large effect size
  2. *p < 0.05, **p < 0.01, ***p < 0.001
  3. aOne or more of emphysema or chronic bronchitis
  4. bOne or more of congestive heart failure, coronary heart disease, angina, heart attack or myocardial infarction, stroke
  5. cAlso adjusting for number of health conditions
Back to article page

International Journal for Equity in Health

ISSN: 1475-9276

Contact us